Eli Lilly and Company presented oncology data at the European Society for Medical Oncology (ESMO) Congress.
5 reports, 1 independent
Updated Oct 24
Gone quiet
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly and Company presented oncology data at the European Society for Medical Oncology (ESMO) Congress.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
European Society for Medical Oncology
Professional organisation
Related events
- Faron Pharmaceuticals presented clinical data at the ESMO Congress on October 19, 2026.
- Zai Lab Limited presented clinical data at the ESMO Congress 2026 in Cambridge, Mass.
- AbbVie presented clinical data at the European Society for Medical Oncology (ESMO) Congress held in Madrid.
- Bristol-Myers Squibb presented clinical data at the European Society for Medical Oncology (ESMO) Congress in Madrid.
- ORIC Pharmaceuticals presented clinical trial data at a medical oncology meeting.